Request Your Free Trend Report Now:

"Inside the Market Strategies of Today's Drugmakers"

Patent protection is expiring for multibillion-dollar medicines later this decade, forcing drugmakers to find new products and markets.

Patent protection is expiring for multibillion-dollar medicines later this decade, forcing drugmakers to find new products and markets. From M&A strategies to emerging therapeutic areas, companies are reshaping their commercial approaches to sustain growth.

included in this trendline

• Novo, Hims reach deal to sell GLP-1 drugs together
• Lilly targets employers in new bid to broaden access to obesity drugs
• White House debuts online service for drug sales

Offered Free by: BioPharma Dive and EVERSANA
See All Resources from: BioPharma Dive and EVERSANA